ACRP and Devana Solutions Annual Metrics Challenge Study in Analysis Stage

(Washington, DC) – December 17, 2018.   ACRP, a nonprofit that sets standards for clinical research competence has been working in collaboration with Devana Solutions (Devana) and industry-leading Site Networks on a study to analyze research site and network performance data based on workforce qualification.   Said Jim Kremidas, ACRP Executive Director, “In support of ACRP’s workforce development goals, we believe it is critical to analyze site staffing, training and development initiatives and their impact on performance. Since Devana Solutions’ IGNITE for sitessoftware helps sites capture key metrics for display and analysis, it is a natural fit to collaborate with them on this study.”  The Annual Metrics Challenge Study was launched in April at the ACRP Annual Conference and continues through April 12, 2019 when the next conference opens in Nashville. The results of the study will help gain insights into the impact of clinical trial training and development programs on trial site effectiveness.

Each site or site network participating in the Site Metrics Challenge Study, utilizes Devana Solutions’ IGNITE for sites platformfor more efficient study start-up and analytics on historic and current trial performanceDevana Solutions’ IGNITE for sitesis a cloud-based platform allows sites to gather data in real time, analyze the results and decision against the analytics to drive process improvement and select more of the right trials from therapeutically and operationally-aligned industry Sponsors and CROs.  The first round of site performance metrics data was gathered from participating sites last month and will be collected and analyzed twice more before results of the study are revealed at ACRP Nashville in 2019.

The study is being headlined by key Research Networks –including LMC Manna I Research and IACT Health, with several other sites participating as well.  The study is open to any participating research sites who utilize Devana Solutions IGNITEfor sites technology platform

All participants are excited to be part of this ground-breaking work and shared some thoughts about the challenge.   Said Karri Venn, president of LMC Manna, “For over 20 years we have been on the forefront of clinical trial expertise and support the ARCP’s missing of improving efficiency and effectiveness of clinical trial management.   Given we were using the Devana platform, it was natural to work with the other top site networks to demonstrate each company’s efficiency and effectiveness for the good of the industry.” Added Felicia Irvin, VP Sales and Marketing of IACT Health “We stand behind the ACRP and its rigorous training; we pay for it and reward our employees for getting certified.  With the Devana Solutions overlay, we were in a position to help contribute to the ACRP Annual Metrics Challenge Study.”  Another participant of the challenge, Ashley Meinsenheimer from MedPharmics, saw the value of Devana Solutions’ IGNITE for sitesimmediately given her background in managing large datasets.  Meinsenheimer stated “I was pleased to participate in the ACRP challenge because it provided an opportunity for us to benchmark our site network against the best and it also provided an opportunity to demonstrate the usefulness of the technology to our employees.”

Barry Lake, Co-Founder and CEO of Devana stated “We are delighted to align with ACRP and our partner Site Networks to drive to excellence in clinical research through real time data and analytics.  Site performance data transparency to support the industry-leading trial sites and site networks is our sole focus at Devana.”

Full study results will be shared in the Spring of 2019 during the ACRP Annual Conference.

About ACRP

ACRP supports clinical research professionals through membership, training and development, and certification.  Founded in 1976, ACRP is a Washington, DC-based nonprofit organization with more than 13,000 members who work in clinical research in more than 70 countries. ACRP’s vision is that clinical research is performed ethically, responsibly, and professionally everywhere inthe world. ACRP’s mission is to promote excellence in clinical research.  www.acrpnet.org

Contact:  Jeremy Glunt, media@acrpnet.org(703) 258-3506

About Devana Solutions, LLC.

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites andPROPEL for networks,advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs.  www.devanasolutions.com

 

Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com (608) 285-2151

Devana Solutions’ IGNITE for sites Technology User Base Continues Rapid Growth; Attesting to the Value of Data Analytics in the Clinical Trials Industry

(Chapel Hill, NC) – December 10, 2018.   Devana Solutions® LLC, makers of cloud-based performance data transparency software aimed at standardizing and improving Clinical Trial operations at the site level, today announced several new research partners utilizing its powerful IGNITE for sites technology.  These new clients represent single investigative sites, site networks, site management organizations (SMO), a leading integrated research organization, academic research centers, and span a wide range of therapeutic specialties.

“Our core mission is to provide technology to improve site processes and align the top research organizations with trial Sponsors which can dramatically cut trial cycle time, lower development costs and get therapeutic advances to patients faster” stated Barry Lake, CEO of Devana Solutions “That vision is rapidly becoming reality with our platform becoming the choice of the industry leaders in the research site space. We are truly humbled.”

The IGNITE for sites technology is a robust site metrics-capture and data analytics platform that delivers an industry leading solution for clinical trials management – from initial study lead through critical study start-up stages to patient screening and enrollment.  This allows for a more streamlined and efficient approach to clinical trial management – leading to faster cycle times and better outcomes – at lower costs.

Recent new clients being onboarded onto the Devana IGNITE for sitestechnology include:

  • Cancer Treatment Centers of America (https://www.cancercenter.com/), a national network of five comprehensive cancer care and research centers and three outpatient centers serving cancer patients throughout the U.S.

 

  • Raleigh Neurology Associates Clinical Research Center(http://www.raleighneurology.com/), a key player in the development and consequential approval of many cutting-edge treatment options for neurological conditions including MS, Parkinson’s and Alzheimer’s Disease with up to 100 clinical trials in all phases underway at any given time.

 

  • University of Washington, Division of Cardiology(https://cardiology.uw.edu/about), with over 90 faculty at three hospitals and residence of the “Father of Exercise Cardiology”, Dr. Robert A. Bruce (deceased) who invented the multistage treadmill cardiac stress test in 1963 with the “Bruce Protocol” still taught in medical schools to this day.

 

  • Javara Research(https://www.javararesearch.com/), a team of luminaries in clinical research who have collectively led over 10,000 trials and engaged more than 200,000 people in clinical trials with an innovative model of making clinical trials more accessible to patients by fully integrating industry-sponsored clinical trials into major health systems such as Wake Forest Baptist Medical Center.

 

  • Elias Research Associates(https://www.eliasresearch.com/), a leading Study Management Organization (SMO) providing professional administrative and financial services to accelerate study start-up for specialists across the U.S. in almost every medical indication.

About Devana Solutions, LLC

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites andPROPEL for networks,advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs.  www.devanasolutions.com 

Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com (608) 285-2151

IGNITE for sites Growth Demonstrates Value of Data Analytics in Clinical Trials

(Chapel Hill, NC) – December 10, 2018.   Devana Solutions® LLC, makers of cloud-based performance data transparency software aimed at standardizing and improving Clinical Trial operations at the site level, today announced several new research partners utilizing its powerful IGNITE for sites technology.  These new clients represent single investigative sites, site networks, site management organizations (SMO), a leading integrated research organization, academic research centers, and span a wide range of therapeutic specialties.

“Our core mission is to provide technology to improve site processes and align the top research organizations with trial Sponsors which can dramatically cut trial cycle time, lower development costs and get therapeutic advances to patients faster” stated Barry Lake, CEO of Devana Solutions “That vision is rapidly becoming reality with our platform becoming the choice of the industry leaders in the research site space. We are truly humbled.”

The IGNITE for sites technology is a robust site metrics-capture and data analytics platform that delivers an industry leading solution for clinical trials management – from initial study lead through critical study start-up stages to patient screening and enrollment.   This allows for a more streamlined and efficient approach to clinical trial management – leading to faster cycle times and better outcomes – at lower costs.

Recent new clients being onboarded onto the Devana IGNITE for sites technology include:

  • Cancer Treatment Centers of America (https://beta.cancercenter.com/), a national network of five comprehensive cancer care and research centers and three outpatient centers serving cancer patients throughout the U.S.
  • Raleigh Neurology Associates Clinical Research Center (http://www.raleighneurology.com/), a key player in the development and consequential approval of many cutting-edge treatment options for neurological conditions including MS, Parkinson’s and Alzheimer’s Disease with up to 100 clinical trials in all phases underway at any given time.
  • University of Washington, Division of Cardiology (https://cardiology.uw.edu/about), with over 90 faculty at three hospitals and residence of the “Father of Exercise Cardiology”, Dr. Robert A. Bruce (deceased) who invented the multistage treadmill cardiac stress test in 1963 with the “Bruce Protocol” still taught in medical schools to this day.
  • Javara Research (https://www.javararesearch.com/), a team of luminaries in clinical research who have collectively led over 10,000 trials and engaged more than 200,000 people in clinical trials with an innovative model of making clinical trials more accessible to patients by fully integrating industry-sponsored clinical trials into major health systems such as Wake Forest Baptist Medical Center.
  • Elias Research Associates (https://www.eliasresearch.com/), a leading Study Management Organization (SMO) providing professional administrative and financial services to accelerate study start-up for specialists across the U.S. in almost every medical indication.About Devana Solutions, LLCDevana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites and PROPEL for networks, advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs.  www.devanasolutions.com   

    Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com  (608) 285-2151

Javara chooses Devana IGNITE for sites software platform to fuel its Integrated Research Organization (IRO)

(CHAPEL HILL, NC) – October 18, 2018.   Devana Solutions, LLC (“Devana”) is pleased to join in supporting Javara’s goal of creating a more relevant clinical trial experience for value-oriented healthcare systems and their patients.   With Javara running Devana’s performance data transparency software platform, enhanced predictive clinical research delivery models become a reality, allowing for improved access to cutting edge therapies and better outcomes within patient–centered care across academic medical centers and healthcare systems.

Javara’s unqiue model and strategy to integrate clinical research within the care continuum, aligning with population health strategies of academic medical centers and healthcare systems, stands to revolutionize the way in which clinical trials are conducted.  Javara’s CEO and Board Chair, Jennifer Byrne, stated “On this journey of bringing more patients to clinical trials as part of their care, Devana’s IGNITE for sites platform is a key technology in advancing the IRO model and offerings of Javara as a reliable solution for both healthcare and biopharmaceutical partners.”

Added Barry Lake, CEO of Devana “We are delighted to align with Javara to provide innovative solutions that drive value for patients, healthcare systems and biopharmaceutical companies and CROs. At Devana Solutions, we wanted to create a suite of products that would connect key stakeholders within the clinical trials ecosystem through better data allowing for better decisions and better outcomes.  Javara’s strategy and offerings are unique and there’s no doubt they will drive better outcomes for their health system clients, while contributing to the advancement of the drug development process. ”

Javara is currently onboarding the IGNITE software for immediate use to enhance business decisions and performance outcomes.

About Devana Solutions, LLC.

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites and PROPEL for networks, advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs. To learn more visit https://devanasolutions.com

CONTACT:

Matt Smith, Executive Director, Strategic Partnerships

msmith@devanasolutions.com

(608) 285-2151

Devana Solutions IGNITE for sites and RealTime-CTMS announce integration to unify best in class CTMS and robust data analytics and insights.

(CHAPEL HILL, NC) October 5, 2018 – Devana Solutions, LLC (“Devana”) is pleased to announce an integration of its robust data analytics and insights software Devana IGNITE for sites  and Real Time’s intuitive CTMS software to deliver an industry leading solution for research sites.   Clinical trials can now be seamlessly managed from initial study lead through the critical study start-up stages in Devana IGNITE to patient screening, enrollment and trial completion in RealTime-CTMS.   This integration will be available for demonstration at the upcoming SCRS – Site Solutions Summit in Boca Raton, Florida starting October 12, 2018.

The combined technologies allow for a more streamlined approach to collecting data by eliminating the need to input critical study information into separate systems.  Essentially, all data captured in either system is automatically transferred into and seamlessly displayed in the other platform.

“Devana’s IGNITE for sites robust start-up and analytics platform integrated with RealTime-CTMS is a winning combination for a complete end-to end solution for managing research site operations. This will give the top research sites and site networks a significant competitive advantage in reducing cycle time for their client  Sponsors and CROs” said Barry Lake, CEO of Devana.   Added Rick Greenfield, CEO of RealTime-CTMS, “We are very excited about this powerful integration. As leading software providers in our respective spaces, sites and site networks will now be able to leverage the power of both systems to streamline the flow of data, eliminate redundant data entry and make the management of business development, contact management, start-up activities, study execution and performance metrics easier and faster.”

For a limited time, current and new customers will receive a discount on the integrated software.   Research site customers of both companies are encouraged to contact their Devana Solutions or RealTime representatives for more information or a demonstration.

Both companies are building upon their long-standing commitment to meet customer needs and develop innovative solutions to empower investigative sites to conduct the world’s best research.

About Devana Solutions, LLC.

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites and PROPEL for networks, advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs. To learn more visit https://devanasolutions.com

CONTACT:

Matt Smith, Executive Director, Strategic Partnerships

msmith@devanasolutions.com

(608) 285-2151

 

About RealTime-CTMS:

RealTime-CTMS is designed to provide quick and easy access to study or subject information utilizing simple and intuitive navigation.   In most cases, needed information is only a few clicks away.  RealTime- stakeholders. To learn more visit https://realtime-ctms.com

CONTACT:

Rick Greenfield, CEO

rgreenfield@realtime-ctms.com

(210) 852-4310

 

Reflections on the Early Stages of Creative Disruption in the Clinical Trial Site Sector and the Tipping Point now finally upon us

(Chapel Hill, NC) April 11, 2018 –  Title:  Reflections on the Early Stages of Creative Disruption in the Clinical Trial Site Sector and the Tipping Point now finally upon us

By Barry Lake, CEO & Co-Founder, Devana Solutions®

Last Wednesday, April 11, 2018 we were proud to issue a joint press release with the Association of Clinical Research Professionals for the ACRP-Devana Solutions® 1st Annual Site Metrics Challenge Study.

We are very honored to work with ACRP and three of our valuable site organization partner-clients, IACT Health, LMC I Manna Research, and PMG Research, to analyze site and network timing and performance metrics data relative to clinical site staff training and development initiatives. The year-long Study in support of ACRP’s clinical trials workforce development goals will kick off at the ACRP Expo on April 27 – 30 in the D.C. area (https://devanasolutions.com/04112018-acrp-and-devana-solutions-launch-first-annual-site-metrics-challenge-study/). The upcoming Expo will mark just the second anniversary since Devana Solutions® first launched commercially at the ACRP Expo in Atlanta in April 2016 with our inaugural cloud-based Site Operations Management Software offering now called IGNITE FOR SITES. As a result, the announcement gave me pause to reflect.

What has changed since our upstart tech company embarked upon our quest to bring data transparency to the fragmented and opaque clinical trial site sector where the real work of clinical trials – seeing actual volunteer patient-subjects – truly happens?

It seems like just recently the pharmaceutical industry turned its full attention to efforts to streamline study start-up in a quest to reduce overall trial cycle time and costs. If reducing study start-up time is critical to cutting costs to advance new therapies, then doesn’t it stand to reason that the industry would rapidly gravitate towards those trial sites and site network organizations that employ Devana Solutions® advanced technology? The platform provides cross-functional teams at those early-adopting trial sites and networks with organization-wide transparency into each milestone and pain point in trial start-up so that responsible staff can rapidly mobilize to address bottlenecks and delays in order to clear the way for the important work of patient recruitment and screening? Further, shouldn’t trial sites and networks rapidly embrace such a system to allow their leadership to drive operational improvements to combat recurring start-up hurdles? What if the same advanced system also automatically captured critical site timing and performance metrics allowing those site and network leaders to easily prove their trial management expertise in their chosen therapeutic strengths?

In a drug development industry that is notoriously slow to adopt change, our young company’s efforts at creative disruption through these technological innovations targeting the clinical trial site sector have, admittedly, not inspired a tsunami of industry Sponsor, CRO or site sector demand…until now.

With gratitude to the former INC Research’s, now Syneos Health’s visionary Catalyst Program which continues to forge ahead past usual resistance, the April 11, 2018 announcement of the ACRP – Devana Solutions® 1stAnnual Metrics Challenge Study may well stand as the “tipping point” for our data transparency platform to align top-performing research sites with Sponsors and CROs to reduce drug development costs and cure disease. What gives me confidence to put forward such a claim?

With a nod to Mr. Gladwell’s 3 Rules of Epidemics; specifically, “The Law of the Few” which, in economic terms, manifests itself in the “80/20 Principle or, the idea that in any situation roughly 80% of the ‘work’ will be done by 20% of the participants”, I have recently been sending notes of thanks and taking the opportunity in my daily interactions to thank all of the “connectors”, “mavens” (information specialists) and “salespeople” whom all continue to be tireless advocates of our Devana Solutions® technology. I have been humbled to point out the following to them:

Right now, 3 of the Top 5 Largest Integrated Site Networks or Organizations in the world have embraced the Devana Solutions® IGNITE FOR SITES platform. PMG Research, IACT Health and LMC I Manna Research stand as industry-leaders in the clinical trials site sector. These 3 organizations have the confidence in their capabilities and vision to embrace our platform and leverage data analytics to further improve what are already efficient site operations. I have no doubt this will propel their site organizations even further ahead of their competitors in clinical trial management and execution.

ABOUT DEVANA SOLUTIONS LLC:

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers two platforms, IGNITE FOR SITES, an advanced operations and data analytics technology for sites and site networks and MATCH PERFORMANCE, to provide historical and real-time data capture, aggregation and display to drug development stakeholders. To learn more visit https://devanasolutions.com.

CONTACT:

Matt Smith, Executive Director, Strategic Partnerships

msmith@devanasolutions.com

(608) 285-2151

ACRP and Devana Solutions® Launch First Annual Site Metrics Challenge Study

(Chapel Hill, NC) April 2, 2018  – In Collaboration with Industry-Leading Site Networks

Washington, DC – The Association of Clinical Research Professionals, a non-profit setting standards for clinical research competence and workforce development, and Devana Solutions today announce an initiative to analyze research site and network performance data based on workforce qualification.

The study will analyze site and network timing and performance metrics data relative to clinical site staff training and development initiatives.

The year-long study, known as the 2018-2019 Annual Site Metrics Challenge Study, will be headlined by three industry-leading integrated site networks, including: IACT Health, a 10-site network throughout Georgia; LMC|Manna Research, an 18-site network across Canada; and PMG Research, Inc., a network of 14 integrated sites based in North Carolina and operating in the Mid-Atlantic & Midwest regions.

“In support of ACRP’s workforce development goals, we believe it is critical to analyze site staffing, training, and development training initiatives and their impact on performance,” says Jim Kremidas, ACRP Executive Director. “Since Devana Solutions’ software helps sites capture key metrics for display and analysis, it is a natural fit to collaborate with them on the study.”

“Our industry is notoriously slow to change,” adds Barry Lake, CEO of Devana Solutions, “but it’s starting to realize the need for data and analytics to improve clinical trial efficiency. Now, with industry-leading site networks such as PMG Research, LMC-Manna Research, and IACT Health having embraced our technology to drive operational analysis and improvement, it was a given to have these three leading organizations headline the first Annual Site Metrics Challenge Study.”

“Making the clinical research community stronger is central to ACRP and a core value shared by all leaders in the clinical trials industry,” stated Dr. Jeff Kingsley, CEO, IACT Health, “we are pleased to headline this effort with our industry peers.”

“Training and continuing education have always been central at LMC|Manna Research,” says Karri Venn, President, Research, “and we’ve always been supportive of ACRP’s efforts in raising the standards in the professional development of those involved in clinical research. We applaud ACRP and Devana Solutions in studying performance in such a holistic way and are excited to participate.”

“PMG Research has always embraced technology innovation as an important way to develop our business and fulfil our goal of bringing clinical research to as many people as possible,” says Kathy Cole, PMG’s Associate Director of Feasibility, “so helping lead this study for ACRP and Devana Solutions is a perfect fit.”

The ACRP – Devana Solutions Annual Site Metrics Challenge Study kicks off at the ACRP 2018 annual conference, April 27-30 at National Harbor, MD, just outside Washington, DC, and continues through the ACRP 2019 annual conference. Visit Devana Solutions at ACRP 2018 in Booth 304 to learn more and sign up.

Every research site or network using Devana Solutions’ IGNITE FOR SITES operational platform is encouraged to participate. Site and network category leaders will be recognized at ACRP 2019 in Nashville, TN.

For sites interested in participating but not yet benefitting from the IGNITE FOR SITES technology, Devana Solutions will be running promotional pricing and incentives from now through ACRP 2018.

About ACRP

ACRP supports clinical research professionals through membership, training and development, and certification. Founded in 1976, ACRP is a Washington, DC-based nonprofit organization with more than 13,000 members who work in clinical research in more than 70 countries. ACRP’s vision is that clinical research is performed ethically, responsibly, and professionally everywhere in the world. ACRP’s mission is to promote excellence in clinical research. www.acrpnet.org

About Devana Solutions

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers two platforms, IGNITE FOR SITES and MATCH PERFORMANCE, to provide historical and real-time data capture, aggregation and display to drug development stakeholders. www.devanasolutions.com

Devana Solutions CONTACT:
Cindy Tremblay
+ 1.843.805.4039
ctremblay@devanasolutions.com